Formulation: A solution in chloroform

Purity: ≥98%

• LPI
• PE (soy)

Formulation: A solution in chloroform

Purity: ≥98%

• PE (bovine brain)

Formulation: A 10 mg/ml solution in chloroform

Purity: ≥98% (mixture of acyl chains)

• Cephalin
• PE (sunflower)

Formulation: A solution in chloroform

Purity: ≥98%

• PE (egg)

Formulation: A solid

Purity: ≥95% (mixture)

• PE (bovine liver)

Formulation: A solid

Purity: ≥95% (mixture)

• Cephalin
• PE (E. coli)

Formulation: A solid

Purity: ≥95%

• Cephalin
• PE (bovine heart)

Formulation: A solid

• NBD-PE

Formulation: A 1 mg/ml solution in chloroform

Purity: ≥95% (mixture)

• Sulforhodamine B-PE

Formulation: A solid

Purity: ≥98% (mixture of fatty acids)

• Lyso-PE (egg)
• LPE (egg)
• L-α-lysophosphatidylethanolamine

Formulation: A crystalline solid

Purity: ≥95%

• 16:0 Dimethyl PE
• 1,2-Dipalmitoyl-sn-glycero-3-N,N-dimethyl-Phosphoethanolamine
• 1,2-N,NMe₂DPPE

Formulation: A solid

Purity: ≥90%

• Glycerol 3-phosphorylethanolamine
• Glycerylphosphorylethanolamine

Formulation: A solid

Purity: ≥98%

• NAPE(16:0/16:0/18:2)
• N-Linoleoyl-1,2-Dipalmitoyl-3-PE
• N-Linoleoyl-1,2-Dipalmitoyl-3-Phosphoethanolamine
• N-Linoleoyl-1,2-Dipalmitoyl-3-Phosphatidylethanolamine

Formulation: A solid

Purity: ≥95%

• NAPE(16:0/16:0/18:0)
• N-Stearoyl-1,3-Dipalmitoyl-3-PE
• N-Stearoyl-1,2-Dipalmitoyl-3-Phosphatidylethanolamine
• N-Stearoyl-1,2-Dipalmitoyl-3-Phosphoethanolamine

Formulation: A solid

Purity: ≥95%

• NAPE(16:0/16:0/18:1)
• N-Oleoyl-1,2-Dipalmitoyl-3-PE
• N-Oleoyl-1,2-Dipalmitoyl-3-Phosphoethanolamine
• N-Oleoyl-1,2-Dipalmitoyl-3-Phosphatidylethanolamine

Formulation: A solid

Purity: ≥95%

• N-Palmitoyl-1,2-Dipalmitoyl-sn-glycero-3-Phosphoethanolamine
• N-Hexadecanoyl-1,2-Dihexadecanoyl-sn-glycero-3-Phosphoethanolamine
• NAPE(16:0/16:0/16:0)

Formulation: A solid

Purity: ≥95%

• NBD-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
• NBD-PtdEtn

Formulation: A crystalline solid

Purity: ≥98%

• 1,2-Dimyristoyl-sn-glycero-3-Phosphoethanolamine
• 1,2-DMPE

Formulation: A solid

Purity: ≥90%

• ​C14-PEG (2000)
• 1,2-Dimyristoyl-sn-glycero-3-Phosphoethanolamine-N-methoxy-Polyethylene Glycol-2000
• 1,2-Ditetradecanoyl-sn-glycero-3-Phosphoethanolamine-N-mPEG(2000)
• PtdEtn-(1,2-Dimyristoyl)-N-mPEG(2000)
• 1,2-Dimyristoyl Phosphatidylethanolamine-N-mPEG(2000)
• PE(14:0/14:0)-mPEG(2000)
• 1,2-DMPE-mPEG(2000)

Formulation: A crystalline solid

Purity: ≥95% (9:1 mixture of 1':2' acyl chain positional isomers)

• 1-Palmitoyl-2-Linoleoyl PE
• PLPE
• (1-Palmitoyl, 2-Linoleoyl)-Phosphatidylethanolamine
• (1-Palmitoyl, 2-Linoleoyl)-Phosphoethanolamine

Formulation: A solid

Purity: ≥98%

• N-Acyl-Phosphatidylethanolamine-Hydrolysing Phospholipase D Activator 534
• NAPE-PLD Activator 534

Formulation: A 500 µg/ml solution in ethanol

Purity: ≥98%

• 15(S)-HETE-SAPE
• 15(S)-Hydroxyeicosatetraenoic Acid-SAPE
• 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-Phosphatidylethanolamine

Formulation: 1 mg of DSPE-PEG(2000)-UNO click conjugate

• CD206 Peptide Ligand
• 1,2-Distearoyl Phosphatidylethanolamine-PEG(2000)-UNO
• DSPE-PEG(2000)-SPGAKVR